During a U.S. Senate Finance Committee hearing entitled, “Health Insurance Coverage in America: Current and Future Role of Federal Programs,” U.S. Senator Mike Crapo (R-ID), Ranking Member of the U.S. Senate Finance Committee, questioned Dr. on what the House drug pricing proposals would have on healthcare access and quality, and the types of policies he sees as the right ones.